Cerus (CERS) EBT Margin Growth (3y) (2013 - 2026)
Cerus (CERS) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -480.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -176.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1,391.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 329.00 |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 10,805.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,805.00 |
| Dec 31, 2025 | 2,411.00 |
| Sep 30, 2025 | 224,283.00 |
| Jun 30, 2025 | -1,756.00 |
| Mar 31, 2025 | 6,480.00 |
| Dec 31, 2024 | -4,417.00 |
| Sep 30, 2024 | 403,431.00 |
| Jun 30, 2024 | 247,963.00 |
| Mar 31, 2024 | 377,207.00 |
| Dec 31, 2023 | 3,525.00 |
| Sep 30, 2023 | 23,386.00 |
| Jun 30, 2023 | -129,169.00 |
| Mar 31, 2023 | 2,333.00 |
| Dec 31, 2022 | 7,279.00 |
| Sep 30, 2022 | -214,306.00 |
| Jun 30, 2022 | 4,029.00 |
| Mar 31, 2022 | 6,557.00 |
| Dec 31, 2021 | -21,360.00 |
| Sep 30, 2021 | -394,872.00 |
| Jun 30, 2021 | -219,538.00 |